Ondansetron ODT 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FFL7S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,916
Award facts
- Contract value 100% obligated
- $35,915.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $35,915.88 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of Ondansetron Orally Disintegrating Tablet 8 mg in quantities of 30 tablets. The delivery order, which serves as a child contract under a larger vehicle, carries an ultimate completion date of January 30, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements.
This delivery order is issued under Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 31, 2031. This prime IDC vehicle enables the supply of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The ondansetron supply fulfills critical pharmaceutical needs across the military health system, with the product commonly used for nausea and vomiting management in healthcare settings.
Quick answers
Who was awarded contract SPE2DR26FFL7S?
SPE2DR26FFL7S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FFL7S worth?
The government has obligated $35,916 on SPE2DR26FFL7S.
Is contract SPE2DR26FFL7S an order under another contract?
Yes. SPE2DR26FFL7S is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL7S competed?
The extent of competition for SPE2DR26FFL7S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award